Trainees and Education
Developing the Next Generation of Cancer Care Delivery Researchers
HICOR is committed to advancing high-quality research that drives clinical practice and policy change, and to developing the next generation of leaders in cancer outcomes research.
Bayer | Fred Hutch Post-Doctoral Fellowship in Health Economics and Outcomes Research
The BAYER Fellowship Program is a 2-year post-doctoral fellowship in health econmics and outcomes research. To help meet the growing need for Health Economics and Outcomes Research (HEOR) researchers, the Hutchinson Institute for Cancer Outcomes Research (HICOR) at the Fred Hutchinson Cancer Center, in conjunction with Bayer Healthcare, has curated a unique fellowship program focused on oncology.
About the Fellowship
This fellowship program is designed to train post-doctoral students in advanced techniques pertaining to HEOR evaluation of cancer pharmaceuticals and related health care technologies. The fellowship combines one year of academic research experience in the Public Health Sciences Division of Fred Hutch with one year of industry experience at Bayer HealthCare in New Jersey to provide fellows with both the theoretical tools and the practical experience to become skilled researchers in this increasingly important discipline.
Eligibility Criteria
- Eligible candidates will have a medical degree and/or doctoral-level degree in economics, health economics, epidemiology, or related subjects. For those holding the MD degree, completion of a clinical residency or equivalent experience is encouraged but not required.
- Please be advised: Employment-based visa requirements exclude F-1, H-1B, and E-3 applicants from participating in this fellowship. Please review the guidelines carefully.
Application Requirements
An open position will be posted each year. Interested applicants will submit an application consisting of:
- letter of intent
- curriculum vitae
- three letters of recommendation
Selection Process
- Applications will be submitted through the Fred Hutch employment page.
- Finalists will be invited to an in-person interview at the Fred Hutch and/or live or telephone interviews with DG&OS leaders at Bayer Healthcare.
- Fellows will be selected by a joint committee composed of faculty from HICOR at Fred Hutch and a team at Bayer Healthcare.
“The mentorship and support from the HICOR team helped me to thrive during the entirety of my fellowship. I believe this multifaceted experience has helped me to grow and improve as a researcher through challenging, collaborative projects and supplementary training opportunities.”
- DR. STEFAN ALLEN
Current Fellows & Trainees
Hiba Khan, MD
Dr. Khan is a Senior Research Fellow in the Clinical Research Division & Hutchinson Institute for Cancer Outcomes Research at Fred Hutch. Dr. Khan started her Hematology/Oncology Fellowship in 2020 at Fred Hutch and the University of Washington.
Dr. Khan is a GU oncologist and health outcomes researcher. Her research interests are quality of oncology care, health equity and disparities, and financial toxicity.
C. Natasha Kwendakwema, MD
Dr. Kwendakwema is a Hematology/Oncology Fellow at Fred Hutch and the University of Washington. Dr. Kwendakwema started her fellowship in 2023.
Dr. Kwendakwema is a resident physician in Seattle, Washington. Her research interests in health outcomes include disparities in GI oncology, financial toxicity, and the quality and safety of oncologic care.
Lauren Shih, MD
Dr. Shih is a Hematology/Oncology Fellow at Fred Hutchinson Cancer Center and the University of Washington. She started her fellowship in 2023. She's participating in the BAYER Fellowship Program.
Dr. Shih is a resident physician in Seattle, Washington.
“I am so grateful to be able to work with HICOR during my oncology fellowship. As a trainee, I have had the opportunity to be involved in meaningful research with a broad impact, on both a local, and a larger-scale level. I have gained valuable experience that I will use to build my own career as an outcomes researcher, to continue improving the lives of patients with cancer.”
- DR. HIBA KHAN
Past Fellows & Trainees
Stefan Allen, PharmD
Dr. Allen is a Cost Effectiveness Fellow. Dr. Allen was a former BAYER post-doctoral research fellow who started in 2021 and graduated from the program in 2023.
Dr. Allen is a licensed pharmacist with HEOR experience supporting multiple therapeutic areas concurrently through drug value and treatment pattern data generation using real-world evidence.
Zach Rivers, PharmD, PhD
Dr. Rivers is a Senior Manager of Health Economics and Outcomes Research at Tempus Labs. Dr. Rivers was a former BAYER post-doctoral research fellow who started in 2020 and graduated from the program in 2021.
Yuxian Du, PhD
Dr. Yu is a Senior Manager in Research Strategy at Bayer HealthCare Pharmaceuticals. Dr. Yu was a former BAYER post-doctoral research fellow who started in 2018 and graduated from the program in 2020. During his time as a BAYER fellow, his concentration was Pharmacoeconomics with Advanced Cost-Effectiveness Analysis training at the University of Washington, and he later studied Data Generation & Observational Studies at Bayer Healthcare.
Trung Nguyen, PhD
Dr. Nguyen is a HEOR Manager at Neurocrine Biosciences. Dr. Nguyen was a former BAYER post-doctoral research fellow who started in 2017 and graduated from the program in 2019.
Jeremy Snider, PhD, MPH
Dr. Snider is a Senior Quantitative Scientist at Flatiron Health. Dr. Snider was a former BAYER post-doctoral research fellow who started in 2016 and graduated from the program in 2018.
Cara McDermott, PharmD, PhD, MSc
Dr. McDermott is an Assistant Professor in the Division of Geriatrics, Department of Medicine at Duke University School of Medicine. Dr. McDermott was a former post-doctoral research fellow who started in 2016 and graduated from the program in 2018. She completed a T32 postdoctoral fellowship with the Cambia Palliative Care Center of Excellence at the University of Washington and a K12 with the University of Washington’s Implementation Sciences Training Program.
Poorni Manohar, MD
Dr. Manohar is a practicing medical oncologist specializing in treating breast cancer in Seattle, Washington. Dr. Manohar graduated from the oncology fellowship program in 2020. Dr. Manohar is a former Assistant Professor in the Clinical Research Division at Fred Hutchinson Cancer Center and an Assistant Professor in the Division of Medical Oncology at the University of Washington.
Cristina Merkhofer, MD, MHS
Dr. Merkhofer is a medical oncologist who serves as an associate medical director at Flatiron Health. Dr. Merkhofer was a former hematology and medical oncology fellow who started in 2017 and graduated from the program in 2020. Prior to joining Flatiron, Dr. Merkhofer is a former Assistant Professor in the Division of Medical Oncology at the University of Washington. She subspecialized in treating patients with thoracic and head and neck malignancies. She held a joint appointment with the Hutchinson Institute for Cancer Outcomes Research at the Fred Hutchinson Cancer Center.
Ali Khaki, MD
Dr. Khaki is a medical oncologist and clinical assistant professor at Stanford University School of Medicine. Dr. Khaki was a former hematology and oncology fellow who started in 2019 and graduated from the program in 2020.
Evan Hall, MD, MPhil
Dr. Hall is an Assistant Professor at the University of Washington and an Assistant Professor in the Clinical Research Division at Fred Hutchinson Cancer Center. He's also a practicing medical oncologist who specializes in the treatment of skin cancers (including melanoma) and kidney cancer in Seattle, Washington. Dr. Hall graduated from the hematology and oncology fellowship program in 2019.
Contact Us
Sarah Miller
1100 Fairview Ave. N., M3-B232
Seattle, WA 98109-1024